Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers?

被引：13

作者：

Gavras, I

Gavras, H

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2003年 / 163卷 / 02期

关键词：

D O I：

10.1001/archinte.163.2.240

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：240 / 241

页数：2

共 5 条

[1] BRADYKININ-MEDIATED EFFECTS OF ACE INHIBITION [J].

GAVRAS, I ;

MADIAS, NE ;

PONCE, P ;

WEIGERT, A ;

MOREIRA, J ;

NEVES, P ;

PRATA, M ;

NEGRAO, P ;

SCHRIER, RW .

KIDNEY INTERNATIONAL, 1992, 42 (04) :1020-1029

[2] AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism [J].

Gohlke, P ;

Pees, C ;

Unger, T .

HYPERTENSION, 1998, 31 (01) :349-355

[3] Angiotensin receptors and their therapeutic implications [J].

Griendling, KK ;

Lassegue, B ;

Alexander, RW .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :281-306

[4]

LACOURCIERE Y, 1994, J HYPERTENS, V12, P1387

[5] Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure - Role of kinins and angiotensin II type 2 receptors [J].

Liu, YH ;

Yang, XP ;

Sharov, VG ;

Nass, O ;

Sabbah, HN ;

Peterson, E ;

Carretero, OA .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1926-1935

← 1 →